Revelation Capital Management

Latest statistics and disclosures from Revelation Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are OMIC, AKLI, NPCE, and represent 100.00% of Revelation Capital Management's stock portfolio.
  • Added to shares of these 1 stock: AKLI.
  • Started 1 new stock position in AKLI.
  • Reduced shares in these 2 stocks: NPCE, ACCD.
  • Sold out of its position in ACCD.
  • Revelation Capital Management was a net seller of stock by $-643k.
  • Revelation Capital Management has $4.3M in assets under management (AUM), dropping by -39.76%.
  • Central Index Key (CIK): 0001801811

Tip: Access up to 7 years of quarterly data

Positions held by Revelation Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Revelation Capital Management

Revelation Capital Management holds 3 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Singular Genomics Systems In (OMIC) 83.2 $3.5M 1.4M 2.50
 View chart
Akili (AKLI) 13.1 $556k NEW 246k 2.26
 View chart
Neuropace (NPCE) 3.8 $161k -82% 43k 3.75
 View chart

Past Filings by Revelation Capital Management

SEC 13F filings are viewable for Revelation Capital Management going back to 2021